Commentary: Why Value-Based Pricing’s Time Has Come, and It’s Here to Stay
PHE economist Jason Shafrin talks prices, politics, and the problem of monopolies with eyeforpharma’s Hugh Gosling.
NCQA’s HEDIS® Data Now Incorporated Into Precision for Value’s Qnav® Tool
Life Sciences Companies Now Given Unprecedented Access and Visualization of Quality Performance Data
JOINT PRESS RELEASE
February 8, 2017 – New York, NY – Life sciences companies stand to be the primary beneficiary of a unique license agreement that integrates the industry’s most robust quality performance data available into a single tool. Precision for Value (PFV) has entered into an arrangement with the National Committee for Quality Assurance (NCQA) to incorporate the Healthcare Effectiveness Data and Information Set (HEDIS®) data into the PFV Quality Navigator Tool (Qnav®).
Precision for Value’s Maureen Hennessey Appointed to NQF’s Medicaid Innovation Accelerator Project
Quality and Population Health Expert to Serve on Coordinating Committee and Chair Physical and Mental Health Technical Expert Panel
February 2, 2017 – New York, NY – Precision for Value, the market leader supporting global pharmaceutical companies in demonstrating the value of innovative medical products, today announced that Maureen Hennessey, SVP, Director, Quality and Population Health Systems, has been appointed to the National Quality Forum’s (NQF) Medicaid Innovation Accelerator Project 2016-2017 (IAP). She will serve on the multi-stakeholder coordinating committee and as chair of the technical expert panel (TEP) supporting physical and mental health integration. (more…)
Dan Renick Discusses Trump Healthcare Policy in Managed Healthcare Executive
Precision for Value’s Dan Renick returns to Managed Healthcare Executive to examine potential healthcare policies in the new Trump administration.
Precision’s Dan Renick Discusses Blocked Aetna-Humana Merger in Managed Healthcare Executive
Precision for Value president Dan Renick discusses the fallout from the recently blocked merger between Aetna and Humana, in the latest edition of Managed Healthcare Executive.
Briefing: Best Practices For The Expedited Start-Up Of Oncology Trials
Precision subject matter expert, Tandy Tipps, highlights how oncology sites can work with their development partners to make study start up achievable within 90 days.
Precision for Value Strengthens and Expands Industry-Leading Payer Strategy Team
Tapping Former Payer Decision Makers Brings Unrivaled Insights to Clients
January 5, 2017 – New York, NY – Precision for Value, the market leader in supporting global pharmaceutical and life sciences companies in demonstrating the value and outcomes of innovative medical products, today announced major additions to its Payer Strategy Team with the hiring and promotion of several key executives.
Precision’s Anupam Jena Named One of the 60 Most Powerful People in Healthcare for 2016
Precision is proud to announce that PHE scientific advisor Anupam Jena, MD has been named by Becker’s Hospital Review as one of the 60 most powerful people in healthcare in 2016, joining other influential leaders such as Robert Califf, Frances Collins, David Feinberg, Bill & Melinda Gates, Barack Obama, and Donald Trump. Included in their annual list, Dr. Jena was recognized in part for his study published this year in JAMA that found female physicians at some of the nation’s most prominent public medical schools earn nearly $20,000 less a year on average than their male colleagues.
Congratulations, Dr. Jena!
precisioneffect’s Lotterman and Balagot Participate in MedAd News’ Healthcare Agency Roundtable
Chief Creative Officer Deborah Lotterman and Chief Experience Officer Paul Balagot recently offered their perspectives for MedAd News, as part of their Healthcare Agency Roundtable series.
Briefing: “Care Creativity” Innovations Transform Medicare Advantage Five-Star Plans
Precision for Value’s Maureen Hennessey and Larry Blandford examine Medicare Advantage Five-Star Plans, focusing on innovation– in the latest edition of Journal of Clinical Pathways (JCP).